Clinical Trial Update: Multiple Ascending Doses of PF-04958242 in Subjects With Stable Schizophrenia [Phase 1]

View source ↗

Summary

Phase 1 study reporting multiple ascending doses of PF-04958242 in subjects with stable schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• PF-04958242

Snippet

Sponsor: Biogen | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED | Results posted: 2016-06-14